FDA Advisory Panel Votes in Favor of Granting Emergency Use Authorization for Pfizer's COVID-19 Vaccine for Kids Aged 5-11
Published
The FDA advisory panel authorized Pfizer's COVID-19 vaccine for children aged 5 to 11, paving the way for vaccinations to start as early as next week.
Full Article